tamibarotene has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekimoto, H; Ishigami-Yuasa, M; Kagechika, H | 1 |
Gronemeyer, H; Kagechika, H; Lou, YR; Miettinen, S; Tuohimaa, P | 1 |
2 other study(ies) available for tamibarotene and Cancer of Prostate
Article | Year |
---|---|
Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer.
Topics: Antineoplastic Agents; Benzoates; Cell Line, Tumor; Decitabine; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Male; Prostatic Neoplasms; Pyridines; Receptors, Retinoic Acid; Sulfonamides; Tetrahydronaphthalenes; Vorinostat | 2019 |
Retinoic acid via RARalpha inhibits the expression of 24-hydroxylase in human prostate stromal cells.
Topics: Benzoates; Calcitriol; Cell Line; Cell Line, Tumor; Cells, Cultured; Dibenzazepines; Epithelial Cells; Gene Expression Regulation; Humans; Male; Prostate; Prostatic Neoplasms; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptors; Retinoids; Steroid Hydroxylases; Tetrahydronaphthalenes; Transfection; Tretinoin; Vitamin D3 24-Hydroxylase | 2005 |